Skip to content
2000
Volume 12, Issue 6
  • ISSN: 1573-4110
  • E-ISSN: 1875-6727

Abstract

Cyclovirobuxine D is an active steroid alkaloid distributed in Buxus microphylla and applied in therapeutic practice of cardiovascular disease. This study describes the development of a new CRM, which includes the homogeneity assessment, stability assessment, purity determination, and uncertainty evaluation. DSC method was applied to the value assignment of cyclovirobuxine D for the first time. The certified purity value for the CRM of cyclovirobuxine D is 996.6 mg•g-1 with an extended uncertainty of 0.6 mg•g-1 (k = 2, P = 0.95) by DSC method. The CRM of cyclovirobuxine D can be widely used to quantitative analyses of cyclovirobuxine D and other related pharmaceutical formulations.

Loading

Article metrics loading...

/content/journals/cac/10.2174/1573411011666150918190217
2016-12-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/cac/10.2174/1573411011666150918190217
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test